Glycomimetics inc (GLYC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net loss

-51,470

-57,891

-57,072

-55,395

-50,844

-48,273

-43,624

-39,999

-36,862

-33,281

-32,351

-32,256

-32,186

-31,809

-32,362

-31,676

-13,215

-12,769

-11,281

-10,731

-13,128

-11,121

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

276

279

279

278

276

275

276

277

277

263

244

220

197

190

188

194

194

191

186

175

168

158

0

0

0

Non-cash lease expense

634

620

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

6,654

6,215

5,638

5,222

4,853

4,587

4,401

4,193

4,033

3,760

3,522

3,299

3,080

2,964

2,883

2,777

2,463

2,323

2,161

1,970

1,930

1,635

0

0

0

Changes in assets and liabilities:
Prepaid expenses and other current assets

-770

2,059

1,389

-1,097

-563

-943

1,589

2,981

2,780

2,816

-223

-946

13

36

521

914

-93

-474

130

-346

58

-1,656

0

0

0

Accounts payable

1,303

-1,227

748

-212

-2,022

16

-992

2,644

3,331

1,061

384

-806

-1,069

1,000

613

284

397

-309

49

624

-623

-270

0

0

0

Accrued expenses

951

2,709

2,562

3,133

1,138

551

832

-981

585

724

743

130

-30

-2,504

-2,156

-1,134

1,108

1,693

2,202

2,637

2,114

4,459

0

0

0

Noncurrent accrued expenses

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-650

-629

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-37

-121

-67

574

578

736

814

182

146

0

0

0

-

-

0

0

Net cash used in operating activities

-41,136

-51,984

-49,171

-45,806

-47,469

-43,331

-41,720

-37,865

-30,915

-29,768

-27,354

-28,596

-29,563

-29,731

-30,734

-9,698

-8,766

-8,241

-7,438

-25,756

-10,399

-4,281

0

0

0

Investing activities
Purchases of property and equipment

113

144

189

197

148

125

102

108

247

294

698

891

749

704

268

101

283

268

280

323

201

212

0

0

0

Net cash used in investing activities

-113

-144

-189

-197

-148

-125

-102

-108

-247

-294

-698

-891

-749

-704

-268

-101

-283

-268

-280

-323

-201

-212

0

0

0

Financing activities
Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

128,425

147,728

147,591

238,538

113,572

95,417

95,417

26,031

23,601

0

0

0

-

-

-

-

57,248

0

0

0

Proceeds from exercise of stock options

512

412

419

737

756

1,024

1,050

669

666

373

225

132

42

72

71

61

74

114

0

0

0

-

-

-

-

Net cash provided by financing activities

512

412

419

737

547

129,449

148,778

148,261

239,204

113,945

95,642

95,550

26,073

23,674

22,525

22,651

1,313

114

116

97

201

57,382

0

0

0

Net change in cash and cash equivalents

-40,737

-51,716

-48,941

-45,267

-47,071

85,992

106,956

110,286

208,041

83,883

67,589

66,062

-4,239

-6,760

-8,477

12,851

-7,736

-8,396

-7,602

-25,983

-10,399

52,888

0

0

0

Non-cash investing and financing activities
Property acquisition costs included in accrued expenses

-

-

-

-

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

0

0

-

-

-

-

Issuance costs associated with financing included in accrued expenses

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance costs associated with the at-the-market financing included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-